Pen Needles Market – Trends Forecast Till 2031

Market Snapshot

Market Overview

The global Pen Needles Market size was estimated at USD 1,790million in 2024 and is projected to reach USD 3,230.3 million in 2031 at a CAGR of 8.8 % during the forecast period 2025-2031.

The pen needles market involves the production and sale of specialized needles used with insulin pens and other injection devices for delivering medications. These needles are designed to provide a comfortable and precise method of administering drugs, primarily for individuals with chronic conditions like diabetes who require frequent injections. The market has grown significantly in recent years, driven by the increasing global prevalence of diabetes and the shift towards more convenient, home-based injection methods. Advancements in needle design and materials have also contributed to greater patient comfort and ease of use, making pen needles a popular choice for self-administration of medications.

The scope of the pen needles market extends across several regions and includes a range of needle sizes and types that cater to different medical needs. While the primary application is in diabetes management, pen needles are also used for other injectable medications, such as hormones and biologics. The market encompasses products for both personal and healthcare professional use, with different requirements for safety, comfort, and precision. As more people manage chronic conditions at home, the demand for convenient, easy-to-use pen needles continues to rise, contributing to the market's expansion.

Key trends in the pen needles market include the growing emphasis on needle safety and the adoption of innovations aimed at improving the user experience. Safety features like retractable needles and safety shields have become increasingly popular to reduce the risk of needlestick injuries. Moreover, the market is witnessing a shift toward smaller, thinner needles to reduce discomfort and enhance the overall experience for patients. Technological innovations in needle design and materials, such as coated and ultra-thin needles, are expected to further enhance patient compliance and satisfaction. Another trend is the rising popularity of reusable insulin pens, which are driving the demand for high-quality, durable pen needles.

The growth of the pen needles market is driven by several factors, including the rising incidence of diabetes worldwide and the increasing shift toward self-management of chronic conditions. The demand for more efficient, less painful injection methods has led to the development of advanced needle technologies, which improve both the comfort and accuracy of drug delivery. Furthermore, the growing adoption of home-based care and the increasing focus on patient-centered healthcare are driving demand for pen needles. As healthcare systems continue to prioritize patient convenience and compliance, the market for pen needles is expected to grow significantly in the coming years.

Delvens Industry Expert's Standpoint

Experts in the Pen Needles Market highlight several key trends driving growth and innovation. The pen needles market involves the production of specialized needles used with insulin pens and other injection devices for delivering medications, mainly for chronic conditions like diabetes. The market has expanded due to the rising prevalence of diabetes, increased adoption of home-based self-injection methods, and improvements in needle design for better comfort and precision. Pen needles cater to both personal and professional use, with various sizes and safety features designed to enhance patient experience. Trends in the market include a focus on safety features like retractable needles, thinner and smaller designs for less discomfort, and advancements in materials to improve needle performance. Growth is driven by the increasing demand for convenient, pain-free injection solutions, technological innovations, and the growing emphasis on patient-centered care in managing chronic diseases like diabetes.

Market Portfolio

Key Findings

• The standard pen needles segment captured the highest share in the global pen needles market due to their affordability, reliability, and compatibility with almost all insulin pens. As the global prevalence of diabetes and other chronic diseases requiring injection therapy continues to rise, the demand for cost-effective and efficient insulin delivery solutions has also increased. Standard pen needles are more economical compared to advanced alternatives, making them the preferred choice for many patients and healthcare providers, particularly in price-sensitive regions. Additionally, these needles are widely available and easily accessible to a broad range of patients. Their simplicity, ease of use, and minimal discomfort contribute to better patient compliance, especially among individuals with long-term diabetes and other chronic conditions, further driving their market dominance.

• The online purchase segment is expected to experience the highest growth rate, driven by the growing consumer shift towards e-commerce. This trend is helping to bridge gaps in supply chain infrastructure, ensuring that pen needles are accessible to customers in remote or underserved regions where retail outlets and pharmacies may be scarce. The convenience of ordering pen needles from home via online platforms is particularly beneficial for patients, as the products are often delivered directly to their doorsteps. This reduces the need for travel and makes accessing diabetes care more convenient, especially for people in distant locations. Online platforms also offer a wider variety of pen needles, often at lower prices, and provide attractive discounts, making them an appealing option for many consumers worldwide.

• The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America region is projected to hold the largest market share. Factors such as increasing prevalence of diabetes, advancements in pen needle technology, growing adoption of self-injection devices, rising healthcare awareness, expanding geriatric population, rising demand for minimally invasive procedures, increased preference for home healthcare, government initiatives and reimbursement policies, growth in diabetes management programs, and innovation in needle design for comfort and safety have triggered the Pen Needles Market in the region.

Regional Analysis

North America to Dominate the Market

• North America's pen needles market holds a dominant position due to the rising demand for pen needles, insulin syringes, and safety products like safety lancets and immunization solutions. Brands such as Droplet and DropSafe are recognized for their patented solutions, focusing on comfort and ease of use for both patients and healthcare professionals. Droplet has gained significant traction as the fastest-growing pen needle brand in North America, with a strong presence in the U.S. Additionally, MTD has captured a large share of the global market in safety lancets, reinforcing the region’s leadership in the sector.

• The U.S. holds a significant share of North America's pen needles market, driven by the increasing prevalence of chronic conditions like diabetes. More patients are turning to insulin pens for self-injection due to their convenience. The market continues to expand with the availability of various needle lengths, including shorter, more comfortable options, and a growing demand for safety features like safety pen needles to reduce needle-stick injuries. Leading brands like Droplet continue to drive innovation and shape the market by offering more comfortable and effective solutions.

• Europe's pen needles market is the largest globally, fueled by a high prevalence of diabetes, the growing use of self-injection devices, and strong healthcare infrastructure. The demand for user-friendly and safety-focused products, such as safety pen needles and shorter needle lengths, continues to drive market growth. In the UK, government initiatives to enhance diabetes care and research further support market expansion, driven by the increasing number of people affected by diabetes across the region.

• The pen needles market in the Asia Pacific region is poised for strong growth, driven by the increasing preference for pen needles over traditional syringes and vials. The aging population in the region is a major factor contributing to the growing demand for user-friendly and convenient injection options. Rising awareness of diabetes management and the adoption of self-injection devices continue to support the market’s expansion. As healthcare infrastructure improves, the use of pen needles is expected to increase, further boosting market growth across the region.

• Japan’s pen needles market is growing due to ongoing technological advancements in medical devices. Innovations such as shorter, finer needles designed for less pain and improved ease of use are contributing to higher adoption rates. Additionally, the integration of smart technology in pen needles for better dose accuracy and patient compliance is further driving market expansion. Japan’s large diabetic population is also a significant factor in the market's growth.

Competitive Landscape

• Embecta Corp.
• Novo Nordisk A/S
• Ypsomed AG
• B. Braun SE
• Owen Mumford
• Terumo Corporation
• NIPRO Corporation
• Allison Medical, Inc.
• AdvaCare Pharma
• Berpu Medical Technology Co., Ltd.
• ARKRAY, Inc.
• GlucoRx Limited
• HTL-STREFA
• UltiMed, Inc.
• Hindustan Syringes and Medical Devices
• Artsana Group
• PromiseMed Medical Devices Inc.
• Montmed, Inc.
• Trividia Health, Inc.
• VOGT Medical Vertrieb GmbH
• Van Heek Medical
• Simple Diagnostics
• IYON Medical
• Links Medical Products, Inc.
• MHC Medical Products, LLC

Recent Developments

• In January 2023, Embecta Corp. (US) further strengthened its presence in New Jersey with the inauguration of a new global headquarters in Parsippany.
• In March 2023, Novo Nordisk A/S (Denmark) announced plans to expand its footprint in the US, with a new research and development hub located near the greater Boston metro area. This initiative aims to create one of the largest R&D centers outside of Denmark.
• In March 2024, MTD (Medical Technology and Devices) (Italy) acquired Ypsomed’s pen needle and blood glucose monitoring (BGM) businesses. This acquisition solidifies MTD’s position as a global leader in pen needle production and strengthens its comprehensive portfolio of diabetes care solutions.

Reasons to Acquire

• Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
• Gain authentic and granular data access for the Pen Needles Market to understand the trends and the factors involved in changing market situations.
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.

Report Scope